Identifying the cause for photoreceptor-mediated retinal-pigmented epithelium atrophy
确定光感受器介导的视网膜色素上皮萎缩的原因
基本信息
- 批准号:10403650
- 负责人:
- 金额:$ 40.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
PI: Claudio Punzo
Project Summary
Retinal-pigmented epithelium atrophy (RPE) that results in geographic atrophy (GA) in humans is one of the
leading causes for blindness in the industrialized world. This is because there is currently no treatment
available to prevent RPE atrophy and thus GA, which is an advanced form of Age-related Macular
Degeneration (AMD). The disease is characterized by focal RPE cell loss. Because the RPE maintains
photoreceptor homeostasis, photoreceptors die as well, which then leads to blindness. Recently, it has been
recognized that the high metabolic demands of photoreceptors may contribute to disease progression in AMD,
in particular, because photoreceptors and RPE metabolism are tightly linked. Two key findings imply
photoreceptors in disease pathogenesis. First, the distribution of soft drusen and subretinal drusenoid deposits
mirrors the distribution of cones and rods, respectively. This has led to the proposal that the metabolic needs
of photoreceptors are what drives deposit formation. Second, macular translocation procedures, which were
developed to save macular cones from dying RPE cells revealed that the new region where the cones where
translocated redeveloped GA. Here it is thought that the high metabolic demands of cones are what causes
RPE stress. However, whether photoreceptor metabolism differs between AMD patients and non-diseased
individuals remained unclear. We recently showed that PRs of AMD patients display signs of nutrient
derivation as they upregulate genes associated with an adaptive response to a glucose shortage. By
mimicking this adaptive response in mouse photoreceptors we were able to induce a subset of pathologies that
are reminiscent of those seen in humans with AMD, including focal RPE atrophy. The goal of this project is to
identify what exactly causes the pathologies seen. We propose in aim 1 to further analyze our model and to
determine how RPE cells die. Thereafter, in aim 2, we will dissect genetically the signaling pathway that we
have used to manipulate photoreceptor metabolism in order to hone in on the metabolic changes that cause
disease. Finally, in aim 3, we will use metabolomics, lipidomics and transcriptomics to identify the underlying
gene expression changes that cause disease and test putative candidate mechanisms in vivo.
Accomplishment of the proposed research will help understand how photoreceptors can cause RPE atrophy.
PI:Claudio Punzo
项目摘要
在人类中导致地理萎缩(GA)的视网膜色素上皮萎缩(RPE)是其中之一
工业化世界中失明的主要原因。这是因为目前没有治疗
可用于防止RPE萎缩,从而可以GA,这是一种与年龄相关的黄斑的高级形式
变性(AMD)。该疾病的特征是局灶性RPE细胞损失。因为RPE保持
感光体稳态,光感受器也死亡,然后导致失明。最近,已经
认识到光感受器的高代谢需求可能导致AMD的疾病进展,
特别是因为光感受器和RPE代谢紧密相连。两个关键发现暗示
疾病发病机理中的感光体。首先,软drusen和视视螺母沉积物的分布
分别反映锥和杆的分布。这导致了代谢需要的提议
光感受器是驱动沉积形成的原因。第二,黄斑易位程序,是
开发以从垂死的RPE细胞中节省黄斑锥的开发表明,锥的新区域
易位的重新开发的GA。在这里,人们认为锥体的高代谢需求是原因
RPE应力。但是,光感受器代谢是否在AMD患者和未诊断的患者之间有所不同
个人仍然不清楚。我们最近表明,AMD患者的PR表现出营养的迹象
推导与对葡萄糖短缺的适应性反应相关的基因上调。经过
模仿小鼠光感受器中的这种适应性反应,我们能够诱导一部分病理学
让人想起那些在AMD的人类中看到的,包括局灶性RPE萎缩。这个项目的目标是
确定到底是什么导致了所见病理。我们建议在AIM 1中进一步分析我们的模型和
确定RPE细胞如何死亡。此后,在AIM 2中,我们将在遗传上剖析我们的信号传导途径
为了磨练引起的代谢变化,用于操纵感光者代谢
疾病。最后,在AIM 3中,我们将使用代谢组学,脂质组学和转录组学来识别基础
基因表达变化,导致疾病并在体内检测假定的候选机制。
拟议研究的完成将有助于了解感光体如何导致RPE萎缩。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Claudio Punzo的其他基金
Identifying the cause for photoreceptor-mediated retinal-pigmented epithelium atrophy
确定光感受器介导的视网膜色素上皮萎缩的原因
- 批准号:1062611310626113
- 财政年份:2021
- 资助金额:$ 40.62万$ 40.62万
- 项目类别:
Identifying the cause for photoreceptor-mediated retinal-pigmented epithelium atrophy
确定光感受器介导的视网膜色素上皮萎缩的原因
- 批准号:1017834310178343
- 财政年份:2021
- 资助金额:$ 40.62万$ 40.62万
- 项目类别:
Testing the role of Glucose deprivation during secondary cone death in Retinitis Pigmentosa
测试葡萄糖剥夺在色素性视网膜炎继发性视锥细胞死亡过程中的作用
- 批准号:99195619919561
- 财政年份:2019
- 资助金额:$ 40.62万$ 40.62万
- 项目类别:
Delaying Cone Death in Retinitis Pigmentosa
延缓色素性视网膜炎中的视锥细胞死亡
- 批准号:85583568558356
- 财政年份:2013
- 资助金额:$ 40.62万$ 40.62万
- 项目类别:
Delaying Cone Death in Retinitis Pigmentosa
延缓色素性视网膜炎中的视锥细胞死亡
- 批准号:91145619114561
- 财政年份:2013
- 资助金额:$ 40.62万$ 40.62万
- 项目类别:
Delaying Cone Death in Retinitis Pigmentosa
延缓色素性视网膜炎中的视锥细胞死亡
- 批准号:87037098703709
- 财政年份:2013
- 资助金额:$ 40.62万$ 40.62万
- 项目类别:
相似国自然基金
基于“肝—眼轴”的枸杞子及其复方防治青少年近视与年龄相关性黄斑变性的功效物质与生物学机制研究
- 批准号:U21A20408
- 批准年份:2021
- 资助金额:260.00 万元
- 项目类别:
基于“肝-眼轴”的枸杞子及其复方防治青少年近视与年龄相关性黄斑变性的功效物质与生物学机制研究
- 批准号:
- 批准年份:2021
- 资助金额:260 万元
- 项目类别:
PGF突变介导的周细胞与内皮细胞crosstalk在湿性年龄相关性黄斑变性中的作用及机制研究
- 批准号:82000898
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
组织病理结构与临床检查对照观察在指导渗出性年龄相关性黄斑变性诊治中的意义研究
- 批准号:81400409
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
基于多模态医学影像技术的湿性年龄相关性黄斑变性诊断与分析
- 批准号:81371629
- 批准年份:2013
- 资助金额:75.0 万元
- 项目类别:面上项目
相似海外基金
Atypical opsins and the OIR model of retinopathy of prematurity
非典型视蛋白与早产儿视网膜病变的 OIR 模型
- 批准号:1067589810675898
- 财政年份:2023
- 资助金额:$ 40.62万$ 40.62万
- 项目类别:
Deciphering the role of mitochondrial/autophagy dysfunction in regulating inflammatory processes during AMD pathogenesis
破译线粒体/自噬功能障碍在 AMD 发病机制中调节炎症过程中的作用
- 批准号:1066411810664118
- 财政年份:2023
- 资助金额:$ 40.62万$ 40.62万
- 项目类别:
OCT-based functional biomarkers for degenerative diseases of the photoreceptor-RPE-choroid neurovascular unit
基于 OCT 的光感受器-RPE-脉络膜神经血管单元退行性疾病的功能生物标志物
- 批准号:1073754810737548
- 财政年份:2023
- 资助金额:$ 40.62万$ 40.62万
- 项目类别:
Identifying mechanistic pathways underlying RPE pathogenesis in models of pattern dystrophy
识别模式营养不良模型中 RPE 发病机制的机制途径
- 批准号:1063667810636678
- 财政年份:2023
- 资助金额:$ 40.62万$ 40.62万
- 项目类别:
Regulators of Photoreceptor Aerobic Glycolysis in Retinal Health and Disease
视网膜健康和疾病中光感受器有氧糖酵解的调节因子
- 批准号:1071782510717825
- 财政年份:2023
- 资助金额:$ 40.62万$ 40.62万
- 项目类别: